Appropriateness of oral anticoagulant therapy and associated factors among hospitalized atrial fibrillation patients with the CHA2DS2-VASc score of 1 (beyond sex)
Open Access
- 30 March 2026
- journal article
- Published by Elsevier in eNeurologicalSci
- Vol. 43, 100610
Abstract
No abstract availableKeywords
Funding Information
- Adigrat University
This publication has 31 references indexed in Scilit:
- Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial FibrillationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2019
- Combining oral anticoagulation and antiplatelet therapies: appropriate patient selectionJournal of Thrombosis and Thrombolysis, 2018
- International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registriesAmerican Heart Journal, 2017
- Underuse of Anticoagulation in Older Patients with Atrial Fibrillation and CHADS2 Score ≥ 2: Are We Doing Better Since the Marketing of Direct Oral Anticoagulants?Drugs & Aging, 2017
- Underuse of Oral Anticoagulants and Inappropriate Prescription of Antiplatelet Therapy in Older Inpatients with Atrial FibrillationDrugs & Aging, 2017
- Outcomes in a Warfarin-Treated Population With Atrial FibrillationJAMA Cardiology, 2016
- Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillationEuropean Journal of Clinical Pharmacology, 2015
- Atrial Fibrillation in the ElderlyDrugs & Aging, 2013
- Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)American Heart Journal, 2006
- Prevalence of Diagnosed Atrial Fibrillation in AdultsJAMA, 2001